Resources for Food and Drug Administration (FDA)
FDA Clears Abbott's Combination Heart Drug
online.wsj.com The Food and Drug Administration granted Abbott Laboratories approval for Simcor, a drug that raises "good" cholesterol and lowers both "bad" cholesterol and triglycerides.
Simcor is a combination of two existing, approved treatments: simvastatin, a statin, and Abbott's Niaspan, an extended-release version of niacin, a B vitamin. Simcor's approval is the first for a cholesterol drug since questions cropped up about the effectiveness of another treatment, Merck & Co. and Schering-Plough Corp.'s Vytorin, and could augur well for FDA approval of Merck's Cordaptive cholesterol-lowering drug, which also is based on niacin.
View the Resource
Share or bookmarklet this web page at:
|
RSS Feeds
